Exploring the Mechanism of Action of Total Glucosides of Paeony Against Autoimmune Thyroiditis Based on Network Pharmacology and Molecular Docking

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2023 Dec 5

PMID 38050229

Authors

Jin Su

Youqing Dong

Xinran Yu

Limin Zhang

Wen Li

Affiliations

Soon will be listed here.

Abstract

The objective of this study is to explore the potential mechanism of action of Total glucosides of paeony (TGP) in the treatment of autoimmune thyroiditis (AIT). The study utilized literature mining to obtain the active ingredients of TGP. Databases such as Super-PRED, similarity ensemble approach, and Swiss Target Prediction were utilized to predict the targets of the active ingredients. DisGeNET, Dangbank, GeneCards, online mendelian inheritance in man, and Pharmgkb databases were used to obtain the targets related to AIT. The Venn Online tool was used to screen the intersecting genes between the active ingredients and AIT targets. The STRING database was employed to analyze protein protein interaction. Gene ontology bio-enrichment and Kyoto encyclopedia of genes and genomes enrichment of common targets were analyzed using R language. Finally, molecular docking was performed using AutoDockTools-1.5.6 software for validation. The study identified 5 active ingredients of TGP, 283 ingredient targets, 7120 disease targets, 220 intersecting targets, 30 entries for gene ontology analysis, and 30 pathways for Kyoto encyclopedia of genes and genomes analysis. The important targets of the protein protein interaction network were identified as interleukin-6, proto-oncogene tyrosine-protein kinase, epidermal growth factor receptor, among others. The molecular docking validation results showed that Paeoniflorin, albiflorin, and benzoylpaeoniflorin and oxypaeoniflor all bind well to interleukin-6, epidermal growth factor receptor, and proto-oncogene tyrosine-protein kinase. This study reveals the multi-component, multi-target and multi-pathway mechanism of action of TGP in regulating AIT and provides a reference for subsequent basic research.

Citing Articles

Traditional Chinese Medicine for Hashimoto's Thyroiditis: Focus on Selenium and Antioxidant Phytochemicals.

Huang S, Ziros P, Chartoumpekis D, Psarias G, Duntas L, Zuo X Antioxidants (Basel). 2024; 13(7).

PMID: 39061936 PMC: 11274136. DOI: 10.3390/antiox13070868.

References

Hepp M, Werion A, De Greef A, de Ville de Goyet C, de Bournonville M, Behets C . Oxidative Stress-Induced Sirtuin1 Downregulation Correlates to HIF-1α, GLUT-1, and VEGF-A Upregulation in Th1 Autoimmune Hashimoto's Thyroiditis. Int J Mol Sci. 2021; 22(8). PMC: 8067526. DOI: 10.3390/ijms22083806. View

Yu H, Wang Y, He Z, Chen R, Dai Y, Tang Y . Albiflorin ameliorates mesangial proliferative glomerulonephritis by PI3K/AKT/NF-κB pathway. Hum Exp Toxicol. 2023; 42:9603271221145386. DOI: 10.1177/09603271221145386. View

Martin T, Ilieva K, Visconti A, Beaumont M, Kiddle S, Dobson R . Dysregulated Antibody, Natural Killer Cell and Immune Mediator Profiles in Autoimmune Thyroid Diseases. Cells. 2020; 9(3). PMC: 7140647. DOI: 10.3390/cells9030665. View

Zheng M, Liu C, Fan Y, Yan P, Shi D, Zhang Y . Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease. Neuropharmacology. 2017; 116:412-420. DOI: 10.1016/j.neuropharm.2017.01.009. View

Cai Z, Liu J, Bian H, Cai J . Albiflorin alleviates ovalbumin (OVA)-induced pulmonary inflammation in asthmatic mice. Am J Transl Res. 2020; 11(12):7300-7309. PMC: 6943473. View

Zhang L, Wei W . Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther. 2019; 207:107452. DOI: 10.1016/j.pharmthera.2019.107452. View

Zhao L, Wu Q, Wang X, Wang S, Shi X, Shan Z . Reversal of Abnormal CD4+ T Cell Metabolism Alleviates Thyroiditis by Deactivating the mTOR/HIF1a/Glycolysis Pathway. Front Endocrinol (Lausanne). 2021; 12:659738. PMC: 8211914. DOI: 10.3389/fendo.2021.659738. View

Ma Y, Lang X, Yang Q, Han Y, Kang X, Long R . Paeoniflorin promotes intestinal stem cell-mediated epithelial regeneration and repair via PI3K-AKT-mTOR signalling in ulcerative colitis. Int Immunopharmacol. 2023; 119:110247. DOI: 10.1016/j.intimp.2023.110247. View

Zeng L, Zhou H, Tang N, Zhang W, He G, Hao B . Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells. World J Gastroenterol. 2016; 22(20):4868-80. PMC: 4873879. DOI: 10.3748/wjg.v22.i20.4868. View

10.

Ragusa F, Fallahi P, Elia G, Gonnella D, Paparo S, Giusti C . Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019; 33(6):101367. DOI: 10.1016/j.beem.2019.101367. View

11.

Zhou Z, Wang S, Song C, Hu Z . Paeoniflorin prevents hypoxia-induced epithelial-mesenchymal transition in human breast cancer cells. Onco Targets Ther. 2016; 9:2511-8. PMC: 4854234. DOI: 10.2147/OTT.S102422. View

12.

Zhong W, Li E, Hao R, Zhang J, Jin H, Lin S . Anti-anaphylactic potential of benzoylpaeoniflorin through inhibiting HDC and MAPKs from Paeonia lactiflora. Chin J Nat Med. 2021; 19(11):825-835. DOI: 10.1016/S1875-5364(21)60086-9. View

13.

Guohua F, Tieyuan Z, Rui W, Juan X . Oxypaeoniflorin Prevents Acute Lung Injury Induced by Lipopolysaccharide through the PTEN/AKT Pathway in a Sirt1-Dependent Manner. Oxid Med Cell Longev. 2021; 2021:6878026. PMC: 8357472. DOI: 10.1155/2021/6878026. View

14.

Zhang J, Wang F, Wang H, Wang Y, Wu Y, Xu H . Paeoniflorin inhibits proliferation of endometrial cancer cells via activating MAPK and NF-κB signaling pathways. Exp Ther Med. 2017; 14(6):5445-5451. PMC: 5740769. DOI: 10.3892/etm.2017.5250. View

15.

Zhong M, Song W, Xu Y, Ye Y, Feng L . Paeoniflorin ameliorates ischemic neuronal damage in vitro via adenosine A1 receptor-mediated transactivation of epidermal growth factor receptor. Acta Pharmacol Sin. 2015; 36(3):298-310. PMC: 4349929. DOI: 10.1038/aps.2014.154. View

16.

Sabbah D, Hajjo R, Sweidan K . Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors. Curr Top Med Chem. 2020; 20(10):815-834. DOI: 10.2174/1568026620666200303123102. View